Autoimmune and Inflammatory Diseases
If immune system mistakenly attacks your own body then it is called as autoimmune disease. Generally, the immune system protects body against bacteria and viruses. But in an autoimmune disease, the immune system releases autoantibodies that attack healthy cells in body. The most common autoimmune diseases are Rheumatoid arthritis, Psoriasis, Psoriatic arthritis, lupus, type 1 diabetes mellitus, Guillain Barre Syndrome, Hashimoto’s thyroiditis, Myasthenia gravis and Vasculitis.
- Guillain Barre Syndrome
- Myasthenia gravis
- Vasculitis
Related Conference of Autoimmune and Inflammatory Diseases
March 24-25, 2027
10th International Conference on Vaccines, Immunology and Clinical Trials
Paris, France
July 27-28, 2027
8th International conference on Vaccines, Vaccination and Immunization
Paris, France
Autoimmune and Inflammatory Diseases Conference Speakers
Recommended Sessions
- Adaptive immune system
- Autoimmune and Inflammatory Diseases
- Diabetes Vaccines
- Haematopoietic, Lymphoid Malignancies and Immune System Development
- HIV Vaccines
- How deadly is the Coronavirus?
- Human Vaccines-Infectious and Non Infectious
- Immunization and Bioterrorism
- Immunogenetics
- Immunotherapy
- Nanotechnology in Vaccine Delivery System
- Pediatric Vaccination
- Travel Immunization
- Vaccination for pregnant women
- Vaccine Adjuvants and Delivery Technologies
- Vaccines and Immunization
- Vaccines for Immune mediated Disease
- Vaccines for Unconventional Diseases
- Vaccines Preclinical and Clinical Trials
- Veterinary Vaccines
Related Journals
Are you interested in
- Adaptive Immunity and Immune Regulation - Vaccines R&D 2027 (France)
- Adult and Healthy Aging Vaccination - Vaccines-Immunization-2027 (France)
- Advanced Vaccine Research and Innovation - VACCINE CONGRESS 2026 (Japan)
- Advances in Vaccine Research and Development - Vaccines-Immunization-2027 (France)
- Allergy and Clinical Immunology - Vaccines R&D 2027 (France)
- Artificial Intelligence in Vaccine Discovery - Vaccines R&D 2027 (France)
- Artificial Intelligence in Vaccine Research - VACCINE CONGRESS 2026 (Japan)
- Artificial Intelligence, Digital Health and Vaccine Innovation - Vaccines-Immunization-2027 (France)
- Autoimmunity and Immune Disorders - Vaccines R&D 2027 (France)
- Bioinformatics and Computational Immunology - Vaccines R&D 2027 (France)
- Biomarkers in Immunology and Clinical Research - Vaccines R&D 2027 (France)
- Biostatistics and Epidemiology in Vaccine Research - VACCINE CONGRESS 2026 (Japan)
- Biotechnology and Vaccine Engineering - VACCINE CONGRESS 2026 (Japan)
- Cancer Vaccines and Immunotherapy - Vaccines R&D 2027 (France)
- Childhood Vaccination and Routine Immunization - Vaccines-Immunization-2027 (France)
- Clinical Trial Design and Regulatory Affairs - Vaccines R&D 2027 (France)
- Clinical Trials and Vaccine Evaluation - VACCINE CONGRESS 2026 (Japan)
- Clinical Trials in Vaccinology - Vaccines R&D 2027 (France)
- Clinical Vaccinology and Immunization Practice - VACCINE CONGRESS 2026 (Japan)
- Cold Chain, Storage and Vaccine Delivery Systems - Vaccines-Immunization-2027 (France)
- Digital Health in Clinical Trials - Vaccines R&D 2027 (France)
- Emerging & Re-emerging Infectious Diseases - Vaccines R&D 2027 (France)
- Emerging and Neglected Disease Vaccines - Vaccines-Immunization-2027 (France)
- Emerging Trends in Vaccine Science - VACCINE CONGRESS 2026 (Japan)
- Ethical, Legal and Regulatory Aspects of Clinical Research - Vaccines R&D 2027 (France)
- Future of Vaccines and Pandemic Preparedness - Vaccines-Immunization-2027 (France)
- Global Health and Vaccine Equity - VACCINE CONGRESS 2026 (Japan)
- Global Immunization Programmes and Public Health - Vaccines-Immunization-2027 (France)
- Global Vaccination Programs and Public Health - Vaccines R&D 2027 (France)
- HPV Vaccination and Cancer Prevention - Vaccines-Immunization-2027 (France)
- Immunogenetics and Genomic Medicine - Vaccines R&D 2027 (France)
- Immunology and Host Immune Response - VACCINE CONGRESS 2026 (Japan)
- Immunology and Immune System Mechanisms - Vaccines R&D 2027 (France)
- Industrial Vaccine Manufacturing and Scale Up - VACCINE CONGRESS 2026 (Japan)
- Infectious Diseases and Immunization Strategies - Vaccines R&D 2027 (France)
- Influenza, RSV and Respiratory Virus Vaccines - Vaccines-Immunization-2027 (France)
- Innovations in Vaccines, Immunology and Clinical Trials - Vaccines R&D 2027 (France)
- Maternal, Neonatal and Adolescent Immunization - Vaccines-Immunization-2027 (France)
- Monoclonal Antibodies and Biologics - Vaccines R&D 2027 (France)
- mRNA and Nucleic Acid Vaccines - Vaccines-Immunization-2027 (France)
- mRNA, DNA & Viral Vector Vaccines - Vaccines R&D 2027 (France)
- Mucosal and Innate Immunity - Vaccines R&D 2027 (France)
- Nanotechnology in Vaccine Delivery - VACCINE CONGRESS 2026 (Japan)
- Next Generation Vaccines and Emerging Technologies - VACCINE CONGRESS 2026 (Japan)
- Next-Generation Vaccine Technologies - Vaccines R&D 2027 (France)
- Next-Generation Vaccine Technologies - Vaccines-Immunization-2027 (France)
- Pandemic Preparedness and Vaccine Development - Vaccines R&D 2027 (France)
- Pediatric and Adult Immunization - Vaccines R&D 2027 (France)
- Personalized Vaccinology and Precision Immunization - VACCINE CONGRESS 2026 (Japan)
- Precision Immunology and Personalized Vaccines - Vaccines R&D 2027 (France)
- Public Health and Immunization Policy - VACCINE CONGRESS 2026 (Japan)
- Regulatory Affairs and Vaccine Approval Systems - VACCINE CONGRESS 2026 (Japan)
- Regulatory Affairs and Vaccine Policy - Vaccines-Immunization-2027 (France)
- Therapeutic Vaccines - Vaccines R&D 2027 (France)
- Translational Immunology - Vaccines R&D 2027 (France)
- Vaccine Adjuvants and Delivery Systems - Vaccines R&D 2027 (France)
- Vaccine Clinical Trials and Evaluation - Vaccines-Immunization-2027 (France)
- Vaccine Delivery Systems and Formulations - VACCINE CONGRESS 2026 (Japan)
- Vaccine Design and Molecular Biology - VACCINE CONGRESS 2026 (Japan)
- Vaccine Discovery and Development - VACCINE CONGRESS 2026 (Japan)
- Vaccine Equity, Access and Global Health - Vaccines-Immunization-2027 (France)
- Vaccine Hesitancy, Confidence and Public Communication - Vaccines-Immunization-2027 (France)
- Vaccine Immunology and Immune Responses - Vaccines-Immunization-2027 (France)
- Vaccine Manufacturing and Quality Control - Vaccines R&D 2027 (France)
- Vaccine Manufacturing, Quality Control and Scale-Up - Vaccines-Immunization-2027 (France)
- Vaccine Research and Development - Vaccines R&D 2027 (France)
- Vaccine Safety and Pharmacovigilance - VACCINE CONGRESS 2026 (Japan)
- Vaccine Safety, Efficacy & Pharmacovigilance - Vaccines R&D 2027 (France)
- Vaccine Safety, Pharmacovigilance and Adverse Events - Vaccines-Immunization-2027 (France)
- Viral and Bacterial Vaccine Research - VACCINE CONGRESS 2026 (Japan)

